Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127)Results of a Randomized, Double-blind, Placebo-Controlled Trial
Fein, Alan M.Volume:
277
Language:
english
Journal:
JAMA: The Journal of the American Medical Association
DOI:
10.1001/jama.1997.03540300050033
Date:
February, 1997
File:
PDF, 1.03 MB
english, 1997